Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -82.48%2.82M | 32,172.55%16.36M | 103.15%27.7M | -27.83%57.7M | 101.71%28.02M | 130.60%16.09M | -100.25%-51K | -64.97%13.64M | 1,114.68%79.95M | -40.22%13.89M |
| Net income from continuing operations | 23.66%7.37M | 76.62%18.33M | 35.66%18.38M | 29.14%64.08M | 608.47%34.19M | -3.54%5.96M | -20.22%10.38M | -47.08%13.55M | 2,531.12%49.62M | 14.04%4.83M |
| Operating gains losses | -120.46%-358K | 1,156.36%581K | 154.60%1.15M | -186.02%-2.4M | -152.39%-1.99M | 157.99%1.75M | 63.58%-55K | -197.24%-2.11M | 408.29%2.79M | -52.05%3.79M |
| Depreciation and amortization | -1.30%7.19M | 41.48%9.11M | 51.58%8.69M | -4.45%28.48M | 50.01%9.03M | -12.69%7.28M | -18.13%6.44M | -24.39%5.74M | 934.18%29.81M | 115.20%6.02M |
| Asset impairment expenditure | --0 | --0 | --0 | -200.00%-8.88M | --0 | --0 | ---5.79M | ---3.09M | --8.88M | --8.88M |
| Unrealized gains and losses of investment securities | ---- | ---- | 6,450.00%786K | ---- | ---- | ---- | -140.00%-24K | -74.47%12K | ---- | ---- |
| Remuneration paid in stock | 0.41%487K | 13.19%575K | -10.55%1.18M | 26.40%2.76M | 30.17%453K | 44.35%485K | 21.82%508K | 21.38%1.32M | 18.10%2.19M | 29.37%348K |
| Deferred tax | 89.63%11.83M | 49.50%9.57M | 59.84%11.08M | 57.26%20.81M | 32.80%1.24M | -49.27%6.24M | --6.4M | --6.93M | --13.23M | --930K |
| Other non cashItems | -44.39%2.15M | 17.32%4.53M | -32.52%2.8M | 19.87%19.8M | 134.98%7.93M | -13.64%3.86M | -4.10%3.86M | -10.81%4.14M | 6,780.83%16.51M | 1,921.56%3.38M |
| Change In working capital | -1,586.09%-18.78M | -4.19%-10.67M | 4.41%-12.28M | 5.41%-40.75M | -15.91%-16.55M | 94.82%-1.11M | -101.79%-10.24M | -481.09%-12.85M | -7,806.44%-43.08M | -282.23%-14.28M |
| -Change in receivables | 52.70%-2.04M | -78.26%-8.49M | -12.51%-5.32M | ---- | ---- | ---4.32M | ---4.76M | ---4.73M | ---- | ---- |
| -Change in inventory | -1,797.22%-10.37M | 21.70%-5.55M | 5.28%-6.66M | 36.55%-18.25M | 57.32%-4.75M | 107.81%611K | 16.04%-7.09M | -412.10%-7.03M | -2,876,900.00%-28.77M | -249.93%-11.12M |
| -Change in payables and accrued expense | -434.01%-2.12M | -46.61%1.8M | 90.59%-246K | -127.56%-1.94M | -136.26%-2.3M | 96.58%-397K | -58.16%3.37M | -161.81%-2.61M | 650.85%7.04M | 421.43%6.35M |
| -Change in other current assets | -241.96%-4.25M | 189.26%1.57M | -104.28%-65K | 3.75%-20.55M | -145.20%-23.3M | 242.93%2.99M | 62.48%-1.76M | 129.93%1.52M | -5,519.47%-21.35M | -1,083.56%-9.5M |
| Tax refund paid | 15.60%-7.06M | -28.93%-14.89M | ---4.08M | ---26.2M | ---6.29M | ---8.37M | ---11.55M | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -82.48%2.82M | 32,172.55%16.36M | 103.15%27.7M | -27.83%57.7M | 101.71%28.02M | 130.60%16.09M | -100.25%-51K | -64.97%13.64M | 1,114.68%79.95M | -40.22%13.89M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,662.20%-34.73M | -157.46%-43.51M | -106.66%-24.02M | -5.01%-45.97M | -17.17%-15.48M | 82.09%-1.97M | -39.22%-16.9M | -56.49%-11.62M | 58.69%-43.78M | 7.58%-13.21M |
| Net PPE purchase and sale | -1,438.38%-34.95M | -158.88%-44.07M | -106.72%-24.35M | -5.52%-47.01M | -18.99%-15.93M | 79.83%-2.27M | -37.72%-17.02M | -56.37%-11.78M | 58.00%-44.55M | 6.40%-13.39M |
| Interest received (cash flow from investment activities) | -27.24%219K | 354.92%555K | 111.69%326K | 34.51%1.03M | 151.93%456K | 14.89%301K | -44.80%122K | 48.08%154K | 897.40%768K | 1,292.31%181K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,662.20%-34.73M | -157.46%-43.51M | -106.66%-24.02M | -5.01%-45.97M | -17.17%-15.48M | 82.09%-1.97M | -39.22%-16.9M | -56.49%-11.62M | 58.69%-43.78M | 7.58%-13.21M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 10.27%44.22M | -140.64%-5.14M | 477.92%22.82M | 277.60%45.07M | 80.33%-1.63M | 8,990.69%40.1M | 160.15%12.64M | -238.65%-6.04M | -134.28%-25.38M | -59.92%-8.27M |
| Net issuance payments of debt | 388.60%14.66M | -135.45%-5.25M | 2.95%-4.87M | 124.07%8.18M | 169.71%3.46M | -11,709.30%-5.08M | 177.87%14.8M | 49.55%-5.01M | -143.96%-33.96M | -8,615.79%-4.97M |
| Net common stock issuance | 2.22%48.49M | --1.54M | --32.56M | 293.39%47.43M | --0 | --47.43M | --0 | --0 | --12.06M | --0 |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --61K | 592.49%1.75M | --0 | -83.86%1.22M | 10,150.00%201K | --0 | -5.95%253K | -86.57%768K | 26.16%7.57M | -100.17%-2K |
| Interest paid (cash flow from financing activities) | -48.87%-3.22M | -45.31%-3.16M | -70.81%-3.06M | 11.70%-9.36M | 2.06%-3.23M | -8.32%-2.16M | 4.31%-2.18M | 40.90%-1.79M | -25.28%-10.6M | 47.75%-3.3M |
| Net other financing activities | -16,497.89%-15.77M | ---17K | ---1.82M | -429.87%-2.4M | ---2.06M | ---95K | ---- | ---- | 39.57%-452K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 10.27%44.22M | -140.64%-5.14M | 477.92%22.82M | 277.60%45.07M | 80.33%-1.63M | 8,990.69%40.1M | 160.15%12.64M | -238.65%-6.04M | -134.28%-25.38M | -59.92%-8.27M |
| Net cash flow | ||||||||||
| Beginning cash position | 534.21%72.59M | 554.07%102.02M | 279.93%74.02M | 112.74%19.48M | 141.42%66.9M | -64.57%11.45M | -65.47%15.6M | 112.74%19.48M | -74.62%9.16M | 275.84%27.71M |
| Current changes in cash | -77.31%12.3M | -649.04%-32.29M | 758.47%26.5M | 426.26%56.8M | 243.91%10.92M | 1,311.55%54.22M | 66.83%-4.31M | -111.22%-4.02M | 142.55%10.79M | -301.06%-7.59M |
| Effect of exchange rate changes | -64.35%441K | 1,691.88%2.87M | 985.51%1.5M | -383.12%-2.26M | -491.28%-3.8M | 1,105.69%1.24M | 18.52%160K | -14.81%138K | 70.02%-468K | 67.71%-642K |
| End cash Position | 27.56%85.34M | 534.21%72.59M | 554.07%102.02M | 279.93%74.02M | 279.93%74.02M | 141.42%66.9M | -64.57%11.45M | -65.47%15.6M | 112.74%19.48M | 112.74%19.48M |
| Free cash from | -332.53%-32.13M | -62.30%-27.71M | 80.53%3.36M | -69.80%10.69M | 2,312.57%12.09M | 422.42%13.82M | -319.03%-17.07M | -94.08%1.86M | 135.59%35.4M | -94.39%501K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.